M&G PLC Biogen Inc. Transaction History
M&G PLC
- $16.2 Trillion
- Q4 2024
A detailed history of M&G PLC transactions in Biogen Inc. stock. As of the latest transaction made, M&G PLC holds 68,839 shares of BIIB stock, worth $9.45 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
68,839
Previous 8,593
701.11%
Holding current value
$9.45 Million
Previous $1.67 Billion
531.8%
% of portfolio
0.07%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
996Shares Held
130MCall Options Held
1.57MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.3 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.2 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.02 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$677 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $19.8B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...